Key result
The Scytalidium dimidiatum group I intron efficiently generated circular RNAs with minimal innate immune activation, demonstrating its potential as an effective RNA vaccine platform.
Why the study?
Circular RNAs are an increasingly important class of molecules for RNA vaccines and therapeutics, motivating characterization of group I introns for circularization.
Characterization and engineering of group I introns improves the manufacturing process and reduces immunogenicity of circular RNAs for vaccines and therapeutics.
May support low-immunogenicity circRNA vaccine platforms; leaves open human safety and efficacy trials.
Circular RNAs are an increasingly important class of RNA molecules that can be engineered as RNA vaccines and therapeutics. Here, we screened eight different group I introns for their ability to circularize and delineated different features that are important for their function. First, we identified the Scytalidium dimidiatum group I intron as causing minimal innate immune activation inside cells, underscoring its potential to serve as an effective RNA vaccine without triggering unwanted reactogenicity. Additionally, mechanistic RNA structure analysis was used to identify the P9 domain as important for circularization, showing that swapping sequences can restore pairing to improve the circularization of poor circularizers. We also determined the diversity of sequence requirements for the exon 1 and exon 2 (E1 and E2) domains of different group I introns and engineered a S1 tag within the domains for positive purification of circular RNAs. In addition, this flexibility in E1 and E2 enables substitution with less immunostimulatory sequences to enhance protein production. Our work deepens the understanding of the properties of group I introns, expands the panel of introns that can be used, and improves the manufacturing process to generate circular RNAs for vaccines and therapeutics.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2025) studied RNA vaccine development. Scytalidium dimidiatum (Sd) group I intron circular RNA vs. Anabaena group I intron circular RNA or linear mRNA was evaluated on Circularization efficiency and innate immune activation. The Scytalidium dimidiatum group I intron efficiently generated circular RNAs with minimal innate immune activation, demonstrating its potential as an effective RNA vaccine platform.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: